Related references
Note: Only part of the references are listed.Two Members of the SIBLING Family of Proteins, DSPP and BSP, May Predict the Transition of Oral Epithelial Dysplasia to Oral Squamous Cell Carcinoma
Kalu U. E. Ogbureke et al.
CANCER (2010)
Epidermal Growth Factor Receptor Expression and Gene Copy Number in the Risk of Oral Cancer
Mohammed Taoudi Benchekroun et al.
CANCER PREVENTION RESEARCH (2010)
15-Year review of laryngeal and oral dysplasias and progression to invasive carcinoma
Patrick M. Spielmann et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2010)
EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma
Maria Sundvall et al.
EXPERT OPINION ON EMERGING DRUGS (2010)
Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections
Stijn J. H. M. Fleskens et al.
HISTOPATHOLOGY (2010)
Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia
Tieneke B. M. Schaaij-Visser et al.
ORAL ONCOLOGY (2010)
Potentially malignant disorders of the oral and oropharyngeal mucosa; present concepts of management
Isaac van der Waal
ORAL ONCOLOGY (2010)
Photodynamic Therapy for Head and Neck Dysplasia and Cancer
Nestor R. Rigual et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)
Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas
A. Torres-Rendon et al.
BRITISH JOURNAL OF CANCER (2009)
High-Dose Fenretinide in Oral Leukoplakia
William N. William et al.
CANCER PREVENTION RESEARCH (2009)
ΔNp63 Overexpression, Alone and in Combination with Other Biomarkers, Predicts the Development of Oral Cancer in Patients with Leukoplakia
Pierre Saintigny et al.
CLINICAL CANCER RESEARCH (2009)
TREATMENT AND FOLLOW-UP OF ORAL DYSPLASIA - A SYSTEMATIC REVIEW AND META-ANALYSIS
Hisham M. Mehanna et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias
Ivy F. L. Tsui et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
The effect of quitting smoking on the risk of unfavorable events after surgical treatment of oral potentially malignant lesions
B. S. Vladimirov et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Phase I Study of Repeated Intraepithelial Delivery of Adenoviral p53 in Patients With Dysplastic Oral Leukoplakia
Songtao Zhang et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression
A. Torres-Rendon et al.
ORAL ONCOLOGY (2009)
Biomarkers in dysplasia of the oral cavity: A systematic review
Joel Smith et al.
ORAL ONCOLOGY (2009)
Grading systems in head and neck dysplasia: their prognostic value, weaknesses and utility
Stijn Fleskens et al.
HEAD & NECK ONCOLOGY (2009)
p16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia
Gillian L. Hall et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
A Pilot Surrogate Endpoint Biomarker Study of Celecoxib in Oral Premalignant Lesions
Lori J. Wirth et al.
CANCER PREVENTION RESEARCH (2008)
Pilot randomized phase II study of celecoxib in oral premalignant lesions
Vassiliki A. Papaclimitrakopoulou et al.
CLINICAL CANCER RESEARCH (2008)
Podoplanin: A novel marker for oral cancer risk in patients with oral premalignancy
Hidetoshi Kawaguchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement
S. Warnakulasuriya et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)
Natural history of potentially malignant oral lesions and conditions: an overview of the literature
Seamus S. Napier et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)
Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma
Angela J. Yoon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Nomenclature and classification of potentially malignant disorders of the oral mucosa
S. Warnakulasuriya et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2007)
Fenretinide activity in retinoid-resistant oral leukoplakia
SM Lippman et al.
CLINICAL CANCER RESEARCH (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Frequent allelic imbalances at 8p and 11q22 in oral and oropharyngeal epithelial dysplastic lesions
XF Zhou et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long-term results
F Chiesa et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Randomized, double-blind, placebo-controlled phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia
JL Mulshine et al.
CLINICAL CANCER RESEARCH (2004)
Overexpression of matrix metalloproteinase-1 and-9 mRNA is associated with progression of oral dysplasia to cancer
RCK Jordan et al.
CLINICAL CANCER RESEARCH (2004)
Survivin, a potential early predictor of tumor progression in the oral mucosa
L Lo Muzio et al.
JOURNAL OF DENTAL RESEARCH (2003)
Pooled estimate of world leukoplakia prevalence: a systematic review
S Petti
ORAL ONCOLOGY (2003)
Field change and oral cancer: new evidence for widespread carcinogenesis?
PJ Thomson
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2002)
Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions
J Renkonen et al.
VIRCHOWS ARCHIV (2002)
Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management
PJ Thomson et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2002)
Improvements to B cell clonality analysis using PCR amplification of immunoglobulin light chain genes
TC Diss et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2002)
Share Paper
